跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLN-EZETIMIBE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GLN-EZETIMIBE
Authorized
STANDARD
GLN-EZETIMIBE
glenmark pharmaceuticals canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5b125c8f17bf814a
Company
glenmark pharmaceuticals canada inc.
Type
Standard
Approval Details
Approval Id
5b125c8f17bf814a
Drug Approval Canada Name
GLN-EZETIMIBE
Product Name
GLN-EZETIMIBE
Status
Marketed
Status Date
2024-06-17
Original Market Date
2019-07-23
Din
02460750
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.05
Atc Original
C10AX09 EZETIMIBE
Atc Name
c 10 ax 09
Aig Number
0149164001
Company Name
glenmark pharmaceuticals canada inc.
Company Address
1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2
Active Ingredients
EZETIMIBE
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5b125c8f17bf814a
Type
Standard
Back to Health Canada Approvals